Certain Aussie Home-Use IVDs Subject To Full Safety Evaluation – TGA
This article was originally published in The Gray Sheet
Executive Summary
Sponsors of home-use in vitro diagnostics intended for the identification or monitoring of serious conditions will need to demonstrate that lay users are able to obtain comparable results to trained professionals, according to recently-released draft guidelines issued by Australia's Therapeutics Goods Administration
You may also be interested in...
SUD Reprocessing, Tissue Regulation Addressed By Australia’s TGA
Device manufacturers will have a two-year phase-in period to comply with new 1single-use device reprocessing regulatory requirements proposed by Australia's Therapeutic Goods Administration
SUD Reprocessing, Tissue Regulation Addressed By Australia’s TGA
Device manufacturers will have a two-year phase-in period to comply with new 1single-use device reprocessing regulatory requirements proposed by Australia's Therapeutic Goods Administration
Australian IVD Framework Proposal Would Broaden Regulatory Oversight
Australia's proposed regulatory structure for in vitro diagnostic devices would bring new regulatory requirements and costs for a number of products that currently are exempt from oversight